June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
June 7, 2023
Research from UC shows potential promise for a drug as a therapy for certain brain tumors. Local 12 interviewed Rekha Chaudry, MD, of the UC College of Medicine about the study results.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
October 23, 2023
The American Cancer Society has awarded the University of Cincinnati Cancer Center a $360,000 Institutional Research Grant that will provide pilot grant support for early-stage investigators working in cancer-related fields.
February 23, 2024
Five University of Cincinnati College of Medicine and UC health researchers and physicians were among the winners and finalists of the Cincinnati Business Courier's Health Care Heroes Awards 2024.
April 10, 2023
Chances are, you know someone whose life is impacted by cancer. In Greater Cincinnati alone, one in two men and one in three women will receive a cancer diagnosis.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.
April 15, 2020
Understanding that time was of the essence in combating this highly infectious disease, UC and its College of Medicine’s Office of Research conducted a rapid review and distribution of $425,000 in novel pilot grants to researchers, focusing on eradicating the disease.